Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Foley

Showing results (151-160 of 167) with videos related to

Pageof 17
Sort By:
European Heart Journal. Digital Health|January 30, 2023
Daily angina documentation versus subsequent recall: development of a symptom smartphone appAlexandra N Nowbar, James P Howard, Matthew J Shun-Shin, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 14, 2022
A double-blind randomised placebo-controlled trial of percutaneous coronary intervention for the relief of stable angina without antianginal medications: design and rationale of the ORBITA-2 trialAlexandra N Nowbar, Christopher Rajkumar, Michael Foley, et al.
ACS Infectious Diseases|February 2, 2021
Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford Selectivity over the Human Enzyme through Tight Binding InteractionsJohn Ginn, Xiuju Jiang, Shan Sun, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 22, 2022
Aortic Valve Calcium Score Is Associated With Acute Stroke in Transcatheter Aortic Valve Replacement PatientsMichael Foley, Kerry Hall, James P Howard, et al.
Journal of the American Heart Association|January 26, 2021
Achieving Optimal Medical Therapy: Insights From the ORBITA TrialMichael Foley, Christopher A Rajkumar, Matthew Shun-Shin, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Diversity-oriented synthesis yields a new drug lead for treatment of chagas diseaseSivaraman Dandapani, Andrew R Germain, Ivan Jewett, et al.
Journal of Pharmacological and Toxicological Methods|June 21, 2025
Current practices on the measurement of electrocardiogram and hemodynamic parameters in non-rodent species in regulatory safety assessment studiesJean-Pierre Valentin, Todd Bourcier, Xuan Chi, et al.
Journal of Medicinal Chemistry|July 9, 2025
Discovery of Orally Efficacious Bridged Piperazines as smTNF ModulatorsZhiguo Bian, Robert G Schmidt, Noel S Wilson, et al.
The Journal of Biological Chemistry|April 3, 2016
i-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4Katherine Griffiths, Olan Dolezal, Benjamin Cao, et al.
Journal of Medicinal Chemistry|January 11, 2023
Structure-Activity Relationship Studies of Antimalarial <i>Plasmodium</i> Proteasome Inhibitors─Part IIHao Zhang, John Ginn, Wenhu Zhan, et al.
Pageof 17

Showing results (151-160 of 167) with videos related to

Sort By:
Pageof 17
European Heart Journal. Digital Health|January 30, 2023
Daily angina documentation versus subsequent recall: development of a symptom smartphone appAlexandra N Nowbar, James P Howard, Matthew J Shun-Shin, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 14, 2022
A double-blind randomised placebo-controlled trial of percutaneous coronary intervention for the relief of stable angina without antianginal medications: design and rationale of the ORBITA-2 trialAlexandra N Nowbar, Christopher Rajkumar, Michael Foley, et al.
ACS Infectious Diseases|February 2, 2021
Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford Selectivity over the Human Enzyme through Tight Binding InteractionsJohn Ginn, Xiuju Jiang, Shan Sun, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 22, 2022
Aortic Valve Calcium Score Is Associated With Acute Stroke in Transcatheter Aortic Valve Replacement PatientsMichael Foley, Kerry Hall, James P Howard, et al.
Journal of the American Heart Association|January 26, 2021
Achieving Optimal Medical Therapy: Insights From the ORBITA TrialMichael Foley, Christopher A Rajkumar, Matthew Shun-Shin, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Diversity-oriented synthesis yields a new drug lead for treatment of chagas diseaseSivaraman Dandapani, Andrew R Germain, Ivan Jewett, et al.
Journal of Pharmacological and Toxicological Methods|June 21, 2025
Current practices on the measurement of electrocardiogram and hemodynamic parameters in non-rodent species in regulatory safety assessment studiesJean-Pierre Valentin, Todd Bourcier, Xuan Chi, et al.
Journal of Medicinal Chemistry|July 9, 2025
Discovery of Orally Efficacious Bridged Piperazines as smTNF ModulatorsZhiguo Bian, Robert G Schmidt, Noel S Wilson, et al.
The Journal of Biological Chemistry|April 3, 2016
i-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4Katherine Griffiths, Olan Dolezal, Benjamin Cao, et al.
Journal of Medicinal Chemistry|January 11, 2023
Structure-Activity Relationship Studies of Antimalarial <i>Plasmodium</i> Proteasome Inhibitors─Part IIHao Zhang, John Ginn, Wenhu Zhan, et al.
Pageof 17